BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9384508)

  • 1. ATP, a partial agonist for the P2Z receptor of human lymphocytes.
    Gargett CE; Cornish JE; Wiley JS
    Br J Pharmacol; 1997 Nov; 122(5):911-7. PubMed ID: 9384508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
    Wiley JS; Gargett CE; Zhang W; Snook MB; Jamieson GP
    Am J Physiol; 1998 Nov; 275(5):C1224-31. PubMed ID: 9814970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP.
    Wiley JS; Chen JR; Snook MB; Jamieson GP
    Br J Pharmacol; 1994 Jul; 112(3):946-50. PubMed ID: 7921625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes.
    Gargett CE; Wiley JS
    Br J Pharmacol; 1997 Apr; 120(8):1483-90. PubMed ID: 9113369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ATP4- receptor-operated channel (P2Z class) of human lymphocytes allows Ba2+ and ethidium+ uptake: inhibition of fluxes by suramin.
    Wiley JS; Chen R; Jamieson GP
    Arch Biochem Biophys; 1993 Aug; 305(1):54-60. PubMed ID: 7688203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters.
    Jamieson GP; Snook MB; Thurlow PJ; Wiley JS
    J Cell Physiol; 1996 Mar; 166(3):637-42. PubMed ID: 8600168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on apoptosis of leukemic lymphocytes mediated by purinergic P2z receptors].
    Peng L; Bradley CJ; Wiley JS
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):398-401. PubMed ID: 11189504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-induced [Ca(2+)](i) changes and depolarization in GH3 cells.
    Chung HS; Park KS; Cha SK; Kong ID; Lee JW
    Br J Pharmacol; 2000 Aug; 130(8):1843-52. PubMed ID: 10952673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptor.
    Sluyter R; Shemon AN; Barden JA; Wiley JS
    J Biol Chem; 2004 Oct; 279(43):44749-55. PubMed ID: 15304508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Z purinoceptor, a special receptor for apoptosis induced by ATP in human leukemic lymphocytes.
    Peng L; Bradley CJ; Wiley JS
    Chin Med J (Engl); 1999 Apr; 112(4):356-62. PubMed ID: 11593539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line.
    Humphreys BD; Dubyak GR
    J Immunol; 1996 Dec; 157(12):5627-37. PubMed ID: 8955215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the P2Z/P2X7 receptor in human lymphocytes produces a delayed permeability lesion: involvement of phospholipase D.
    Fernando KC; Gargett CE; Wiley JS
    Arch Biochem Biophys; 1999 Feb; 362(2):197-202. PubMed ID: 9989927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transduction mechanisms of P2Z purinoceptors.
    Wiley JS; Chen JR; Snook MS; Gargett CE; Jamieson GP
    Ciba Found Symp; 1996; 198():149-60; discussion 160-5. PubMed ID: 8879824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoptosis of leukemic lymphocytes mediated by purinergic P2z receptors].
    Peng L; Bradley CJ; Wiley JS
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):508-11. PubMed ID: 10923459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of cation channels and non-selective pores by macrophage P2z purinergic receptors expressed in Xenopus oocytes.
    Nuttle LC; Dubyak GR
    J Biol Chem; 1994 May; 269(19):13988-96. PubMed ID: 7514597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors.
    Conigrave AD; Fernando KC; Gu B; Tasevski V; Zhang W; Luttrell BM; Wiley JS
    Eur J Pharmacol; 2001 Aug; 426(3):157-63. PubMed ID: 11527539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx.
    Michel AD; Grahames CB; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):562-71. PubMed ID: 8938653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative method for routine measurement of cell surface P2X7 receptor function in leucocyte subsets by two-colour time-resolved flow cytometry.
    Jursik C; Sluyter R; Georgiou JG; Fuller SJ; Wiley JS; Gu BJ
    J Immunol Methods; 2007 Aug; 325(1-2):67-77. PubMed ID: 17618646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human epidermal and monocyte-derived langerhans cells express functional P2X receptors.
    Georgiou JG; Skarratt KK; Fuller SJ; Martin CJ; Christopherson RI; Wiley JS; Sluyter R
    J Invest Dermatol; 2005 Sep; 125(3):482-90. PubMed ID: 16117789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
    Gu BJ; Zhang WY; Bendall LJ; Chessell IP; Buell GN; Wiley JS
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1189-97. PubMed ID: 11003599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.